PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33811614-1 2021 The present study aimed to investigate the impacts and underlying mechanisms of 14,15-DHETs on eNOS and vascular endothelial functions. 14,15-dihydroxyeicosatrienoic acid 80-91 nitric oxide synthase 3, endothelial cell Mus musculus 95-99 33811614-7 2021 The impacts of 14,15-DHET (0.4 mg/kg body weight) on the expressions of eNOS protein and mRNA and endothelium-dependent vasodilation (EDV) were detected following 24 h. The expression of eNOS was greatly improved with the 14,15-DHET treatment compared with the BAECs, and eNOS phosphorylation sites at Ser1179, Ser635, and Thr497 were elevated. 14,15-dihydroxyeicosatrienoic acid 15-25 nitric oxide synthase 3, endothelial cell Mus musculus 72-76 33811614-7 2021 The impacts of 14,15-DHET (0.4 mg/kg body weight) on the expressions of eNOS protein and mRNA and endothelium-dependent vasodilation (EDV) were detected following 24 h. The expression of eNOS was greatly improved with the 14,15-DHET treatment compared with the BAECs, and eNOS phosphorylation sites at Ser1179, Ser635, and Thr497 were elevated. 14,15-dihydroxyeicosatrienoic acid 15-25 nitric oxide synthase 3, endothelial cell Mus musculus 187-191 33811614-7 2021 The impacts of 14,15-DHET (0.4 mg/kg body weight) on the expressions of eNOS protein and mRNA and endothelium-dependent vasodilation (EDV) were detected following 24 h. The expression of eNOS was greatly improved with the 14,15-DHET treatment compared with the BAECs, and eNOS phosphorylation sites at Ser1179, Ser635, and Thr497 were elevated. 14,15-dihydroxyeicosatrienoic acid 15-25 nitric oxide synthase 3, endothelial cell Mus musculus 187-191 33811614-7 2021 The impacts of 14,15-DHET (0.4 mg/kg body weight) on the expressions of eNOS protein and mRNA and endothelium-dependent vasodilation (EDV) were detected following 24 h. The expression of eNOS was greatly improved with the 14,15-DHET treatment compared with the BAECs, and eNOS phosphorylation sites at Ser1179, Ser635, and Thr497 were elevated. 14,15-dihydroxyeicosatrienoic acid 222-232 nitric oxide synthase 3, endothelial cell Mus musculus 187-191 33811614-7 2021 The impacts of 14,15-DHET (0.4 mg/kg body weight) on the expressions of eNOS protein and mRNA and endothelium-dependent vasodilation (EDV) were detected following 24 h. The expression of eNOS was greatly improved with the 14,15-DHET treatment compared with the BAECs, and eNOS phosphorylation sites at Ser1179, Ser635, and Thr497 were elevated. 14,15-dihydroxyeicosatrienoic acid 222-232 nitric oxide synthase 3, endothelial cell Mus musculus 187-191 33811614-9 2021 Based on the upregulation of eNOS protein, eNOS mRNA levels were increased in BAECs and thoracic aorta of the male C57BL/6 mice treated with 14,15-DHET, suggesting that transcriptional activation was achieved in vascular eNOS. 14,15-dihydroxyeicosatrienoic acid 141-151 nitric oxide synthase 3, endothelial cell Mus musculus 29-33 33811614-9 2021 Based on the upregulation of eNOS protein, eNOS mRNA levels were increased in BAECs and thoracic aorta of the male C57BL/6 mice treated with 14,15-DHET, suggesting that transcriptional activation was achieved in vascular eNOS. 14,15-dihydroxyeicosatrienoic acid 141-151 nitric oxide synthase 3, endothelial cell Mus musculus 43-47 33811614-9 2021 Based on the upregulation of eNOS protein, eNOS mRNA levels were increased in BAECs and thoracic aorta of the male C57BL/6 mice treated with 14,15-DHET, suggesting that transcriptional activation was achieved in vascular eNOS. 14,15-dihydroxyeicosatrienoic acid 141-151 nitric oxide synthase 3, endothelial cell Mus musculus 43-47 33811614-11 2021 These findings indicated that 14,15-DHET could improve the vascular endothelial diastolic functions of male C57BL/6 mice, and enhance the ability of tube formation, which might be related to the increase of eNOS expression. 14,15-dihydroxyeicosatrienoic acid 30-40 nitric oxide synthase 3, endothelial cell Mus musculus 207-211